Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 05, 2021 9:03pm
190 Views
Post# 32939457

RE:RE:RE:RE:So AVRT

RE:RE:RE:RE:So AVRTSo how does someone get an Aristotle test.  Or how will they get a test.  Yes I know this is day one.

Take me for example I am in canada in an area where ichor operates.  Pretty confident I could get a test and they send it it for processing.  I will assume that puts me into the AVRT program automatically.  All fine and dandy except for the paying of the test.  A $150 covid test is cheap if it means I get to travel but how with a $1500 USD test get handled up in Canada.  Will insurance cover it?

Thats one area of concern as far as wide spread customers go.

Then another example say an American lives in North Dakota how does that person get a test.

Will people be able to go to Care Oncology and get blood drawn to be sent for testing? From what I can find of their clince they are small but in major cities.

If there isnt a bigger plan in store I just dont see how this can ramp up if we go the small clinic route.  To replace our covid testing capacity of 1000 test Stage would have to only do 50 Aristotle tests a day instead which isnt very much when you think about it but how do they get to that number.  They arent at 1000 covid tests a day and its the biggest thing in the past 2 years.  What puts people in the door to get Aristotle.

Yes I realize these questions are very early on in the development but Stage must have some sort of master plan.  I dont see why they cant give us more of an idea of what that will eventually look like or what they are working towards.
<< Previous
Bullboard Posts
Next >>